HOME Top Market Reports Patient Registry Software Market by Registry Type (Drugs, Diabetes, Cancer, Asthma, Orthopedic), Software (Integrated, Standalone), Delivery (On premise, Cloud), Functionality (PHM, HIE, POC), Database (Commercial, Public), End User - Global Forecast to 2022

Patient Registry Software Market by Registry Type (Drugs, Diabetes, Cancer, Asthma, Orthopedic), Software (Integrated, Standalone), Delivery (On premise, Cloud), Functionality (PHM, HIE, POC), Database (Commercial, Public), End User - Global Forecast to 2022

By: marketsandmarkets.com
Publishing Date: August 2017
Report Code: HIT 3094

 

  Speak to Analyst Enquiry Before Buying Webinar
purchase report
download pdf  request for customisation


The global patient registry software market is expected to reach USD 1,429.1 Million by 2022 from USD 807.4 Million in 2016 at a CAGR of 12.1%. The base year considered for the study is 2016 and the forecast period 2017–2022.

The objectives of this study are as follows:

  • To define, describe, and forecast the patient registry software market on the basis of type of registry, pricing model, deployment model, type of database, functionality, end user, type of software, and region
  • To provide detailed information regarding the major factors influencing growth of the market (drivers, restraints, opportunities, and industry-specific challenges)
  • To analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the overall market
  • To forecast the size of the market segments with respect to four main regions, namely, North America, Europe, Asia-Pacific, and the Rest of the World (RoW)
  • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To profile the key players and analyze their product portfolios, market positions, and core competencies
  • To track and analyze competitive developments such as joint ventures; mergers and acquisitions; product developments, partnerships, collaborations, expansions, and research; and other development activities in the patient registry software market

Research Methodology

This research study involved the extensive use of secondary sources; directories; databases such as Hoovers, Bloomberg Business, Factiva, and OneSource; white papers; annual reports; company house documents; and SEC filings of companies. Secondary research was mainly used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the patient registry software market. It was also used to obtain key information about the market classification and segmentation according to the industry trends, regional markets, and developments related to market and technology perspectives. Primary sources were mainly several industry experts from core and related industries; and manufacturers, service providers, technology developers, researchers, and organizations related to all segments of this industry’s value chain.

In-depth interviews were conducted with various primary respondents which included key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify critical qualitative and quantitative information as well as to assess prospects.

Patient Registry Software Market

To know about the assumptions considered for the study, download the pdf brochure

The patient registry software market is fragmented with several big and small players. Players offer several products across different subsegments of this market. Key players in this market include Phytel, Inc. (US), QUINTILES IMS HOLDINGS, INC. (US), Liaison Technologies. (US), ImageTrend, Inc. (US), FIGmd, Inc. (US), McKesson Corporation (US), CECity.com Inc. (a Premier, Inc. Company) (US), Dacima Software Inc. (US), Global Vision Technologies, Inc. (US), ifa systems AG, (Germany), INC RESEARCH HOLDINGS, INC. (US), M2S (A Medstreaming Company) (US), Optum, Inc (A part of UnitedHealth Group Incorporated) (US), EVADO Pty. Ltd. (Australia), and Velos, Inc. (US).

Target Audience for this Report:

  • Patient registry software vendors and service providers
  • Healthcare IT service providers
  • Research and consulting firms
  • Healthcare insurance companies and payers
  • Healthcare institutions/providers (hospitals, medical groups, physician practices, community clinics, and outpatient clinics)
  • Venture capitalists
  • Government agencies
  • Health information exchanges
  • Accountable care organizations (ACOs)
  • Pharmaceutical, biotechnology, and medical device companies

Scope of the Report

The research report categorizes the global market into the following segments and subsegments:

Patient Registry Software Market, by Type of Registry

  • Product Registries
    • Medical Device
    • Drug
  • Health Service Registries
    • Disease Registries
    • Diabetes
    • Cardiovascular
    • Cancer
    • Rare Disease
    • Asthma
    • Orthopedic
    • Chronic Kidney Disease
  • Other Registries (Ophthalmology, Hemophilia Registries, and Neuromuscular Disease)

Patient Registry Software Market, by Type of Software

  • Integrated
  • Standalone

Patient Registry Software Market, by Pricing Model

  • Subscription
  • Ownership

Patient Registry Software Market, by Deployment Model

  • On-premise
  • Cloud-based

Patient Registry Software Market, by Functionality

  • Population Health Management (PHM)
  • Patient Care Management
  • Health Information Exchange (HIE)
  • Point-of-Care
  • Product Outcome Evaluation
  • Medical Research and Clinical Studies

Patient Registry Software Market, by Type of Database

  • Commercial
  • Public

Patient Registry Software Market, by End User

  • Government Organizations and Third-party Administrators (TPAs)
  • Hospitals and Medical Practices
  • Private Payers
  • Pharmaceutical, Biotechnology, and Medical Device Companies
  • Research Centers

Patient Registry Software Market, by Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Rest of Europe (RoE)
  • Asia-Pacific
    • Japan
    • China
    • India
    • Rest of Asia-Pacific (RoAPAC)
  • Rest of the World (RoW)
  • (Latin America, the Middle East, and Africa)

With the given market data, MarketsandMarkets offers customizations as per the company‘s specific needs.

The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (Up to 5)

Geographic Analysis

  • Further breakdown of the RoW segment into Pacific countries, the Middle East and Africa (MEA), and Latin America (LATAM)

Table of Contents

1 Introduction (Page No. - 25)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 30)
    2.1 Market Size Estimation
    2.2 Market Breakdown and Data Triangulation
    2.3 Assumptions for the Study

3 Executive Summary (Page No. - 38)

4 Premium Insights (Page No. - 47)
    4.1 Patient Registry Software: Market Overview
    4.2 Patient Registry Software Market, By Type of Software, 2017 vs 2022 (USD Million)
    4.3 Patient Registry Software Market, By Deployment Model, 2017 vs 2022 (USD Million)
    4.4 Patient Registry Software Market, By Type of Database, 2017 vs 2022 (USD Million)
    4.5 Patient Registry Software Market, By End User, 2017–2022
    4.6 Geographic Snapshot of the Patient Registry Software Market

5 Market Overview (Page No. - 53)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Market Drivers
                    5.2.1.1 Implementation of Government Initiatives to Build Patient Registries
                    5.2.1.2 Rising Pressure to Improve the Quality of Care and Reduce Healthcare Costs
                    5.2.1.3 Rising Adoption of EHRs
                    5.2.1.4 Growing Use of Patient Registry Data for Post-Marketing Surveillance
           5.2.2 Market Restraints
                    5.2.2.1 Privacy- and Data Security-Related Concerns
                    5.2.2.2 Lack of Trained and Skilled Resources
           5.2.3 Market Opportunities
                    5.2.3.1 Rising Number of Accountable Care Organizations
                    5.2.3.2 Emergence of Cloud-Based Patient Registry Solutions
                    5.2.3.3 High Adoption Rate of the Subscription Model
                    5.2.3.4 Shifting Focus Towards Patient-Powered Research Networks (PPRNs)
           5.2.4 Market Challenges
                    5.2.4.1 Lack of Interoperability and Integration
                    5.2.4.2 Reluctance Towards Adopting Advanced Solutions
                    5.2.4.3 Lack of Awareness

6 Patient Registry Software Market, By Type of Registry (Page No. - 62)
    6.1 Introduction
    6.2 Disease Registries
           6.2.1 Diabetes Registries
           6.2.2 Cardiovascular Registries
           6.2.3 Cancer Registries
           6.2.4 Rare Disease Registries
           6.2.5 Asthma Registries
           6.2.6 Chronic Kidney Disease Registries
           6.2.7 Orthopedic Registries
           6.2.8 Other Registries
    6.3 Health Service Registries
    6.4 Product Registries
           6.4.1 Medical Device Registries
           6.4.2 Drug Registries

7 Patient Registry Software Market, By Type of Software (Page No. - 102)
    7.1 Introduction
    7.2 Standalone Software
    7.3 Integrated Software

8 Patient Registry Software Market, By Pricing Model (Page No. - 110)
    8.1 Introduction
    8.2 Subscription Model
    8.3 Ownership Model

9 Patient Registry Software Market, By Deployment Model (Page No. - 118)
    9.1 Introduction
    9.2 On-Premise Models
    9.3 Cloud-Based Models

10 Patient Registry Software Market, By Type of Database (Page No. - 127)
     10.1 Introduction
     10.2 Commercial Databases
     10.3 Public Databases

11 Patient Registry Software Market, By Functionality (Page No. - 135)
     11.1 Introduction
     11.2 Population Health Management (PHM)
     11.3 Patient Care Management
     11.4 Health Information Exchange
     11.5 Point-of-Care
     11.6 Product Outcome Evaluation
     11.7 Medical Research & Clinical Studies

12 Patient Registry Software Market, By End User (Page No. - 155)
     12.1 Introduction
     12.2 Government Organizations & Third-Party Administrators (TPAs)
     12.3 Hospitals and Medical Practices
     12.4 Private Payers
     12.5 Pharmaceutical, Biotechnology, and Medical Device Companies
     12.6 Research Centers

13 Patient Registry Software Market, By Region (Page No. - 171)
     13.1 Introduction
     13.2 North America
             13.2.1 US
             13.2.2 Canada
     13.3 Europe
             13.3.1 Germany
             13.3.2 France
             13.3.3 UK
             13.3.4 Rest of Europe (RoE)
     13.4 Asia-Pacific
             13.4.1 Japan
             13.4.2 China
             13.4.3 India
             13.4.4 Rest of Asia-Pacific (RoAPAC)
     13.5 Rest of the World (RoW)

14 Competitive Landscape (Page No. - 254)
     14.1 Introduction
     14.2 Key Players in Patient Registry Software Market
     14.3 Competitive Leadership Mapping
             14.3.1 Visionary Leaders
             14.3.2 Innovators
             14.3.3 Dynamic Differentiators
             14.3.4 Emerging Companies
     14.4 Strength of Product Portfolio (For 25 Players)
     14.5 Business Strategy Excellence (For 25 Players)

*Top 25 companies analysed for this study are - Phytel, Inc. (An IBM Company), (US), Quintiles IMS Holdings, INC., (US), McKesson Corporation, (US), Inc Research Holdings, INC., (US), Optum, Inc. (a part of UnitedHealth Group Incorporated), (US), Liaison Technologies., (US), CECity.com, Inc. (a Premier, Inc. Company), (US), Ifa systems AG, (Germany), AltaVoice (An Invitae Corporation Company), (US), FIGmd, Inc., (US), Global Vision Technologies, Inc., (US), Dacima Software Inc., (Canada), EVADO Pty. Ltd., (Australia), Velos, Inc., (US), HealthDiary Inc., (Canada), M2S, Inc (A Medstreaming Company)., (US), Lumedx, (US), ImageTrend, Inc., (US), phamax AG, (Switzerland), ArborMetrix, Inc., (US), GZ Software, (US), CEDARON, (US), ARMUS Corporation, (US), VersaForm Systems Corporation, (US), Healthmonix, (US)

15 Company Profiles (Page No. - 259)
(Overview, Strength of Product Portfolio Business Strategy Excellence Products Offering, Recent Development’s, Business Strategy)*
     15.1 Phytel, Inc. (An IBM Corporation Company)
     15.2 ImageTrend, Inc.
     15.3 FIGmd, Inc.
     15.4 Liaison Technologies
     15.5 Cecity.Com, Inc. (A Premier, Inc. Company)
     15.6 Dacima Software, Inc.
     15.7 Global Vision Technologies, Inc. (GVT)
     15.8 Ifa Systems AG
     15.9 Inc Research Holdings, Inc.
     15.10 M2S, Inc. (A Medstreaming Company)
     15.11 McKesson Corporation
     15.12 Quintiles IMS Holdings, Inc.
     15.13 Optum, Inc. (A Part of Unitedhealth Group, Inc.)
     15.14 EVADO Pty. Ltd.
     15.15 Velos, Inc.

*Details on Overview, Strength of Product Portfolio Business Strategy Excellence Products Offering, Recent Development’s, Business Strategy Might Not Be Captured

in Case of Unlisted Companies.

16 Appendix (Page No. - 306)
     16.1 Insights From Industry Experts
     16.2 Discussion Guide/Questionnaire
     16.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
     16.4 Introducing RT: Real-Time Market Intelligence
     16.5 Available Customizations
     16.6 Related Reports
     16.7 Author Details


List of Tables (268 Tables)

Table 1 Global Patient Registry Software Market, By Type of Registry, 2015-2022 (USD Million)
Table 2 Global Disease Registries Market, By Type, 2015-2022 (USD Million)
Table 3 Global Disease Registries Market, By Region, 2015-2022 (USD Million)
Table 4 North America: Disease Registries Market, By Country, 2015-2022 (USD Million)
Table 5 Europe: Disease Registries Market, By Country, 2015-2022 (USD Million)
Table 6 Asia-Pacific: Disease Registries Market, By Country, 2015-2022 (USD Million)
Table 7 Global Diabetes Registries Market, By Region, 2015-2022 (USD Million)
Table 8 North America: Diabetes Registries Market, By Country, 2015-2022 (USD Million)
Table 9 Europe: Diabetes Registries Market, By Country, 2015-2022 (USD Million)
Table 10 Asia-Pacific: Diabetes Registries Market, By Country, 2015-2022 (USD Million)
Table 11 Global Cardiovascular Registries Market, By Region, 2015-2022 (USD Million)
Table 12 North America: Cardiovascular Registries Market, By Country, 2015-2022 (USD Million)
Table 13 Europe: Cardiovascular Registries Market, By Country, 2015-2022 (USD Million)
Table 14 Asia-Pacific: Cardiovascular Registries Market, By Country, 2015-2022 (USD Million)
Table 15 Global Cancer Registries Market, By Region, 2015-2022 (USD Million)
Table 16 North America: Cancer Registries Market, By Country, 2015-2022 (USD Million)
Table 17 Europe: Cancer Registries Market, By Country, 2015-2022 (USD Million)
Table 18 Asia-Pacific: Cancer Registries Market, By Country, 2015-2022 (USD Million)
Table 19 Global Rare Disease Registries Market, By Region, 2015-2022 (USD Million)
Table 20 North America: Rare Disease Registries Market, By Country, 2015-2022 (USD Million)
Table 21 Europe: Rare Disease Registries Market, By Country, 2015-2022 (USD Million)
Table 22 Asia-Pacific: Rare Disease Registries Market, By Country, 2015-2022 (USD Million)
Table 23 Global Asthma Registries Market, By Region, 2015-2022 (USD Million)
Table 24 North America: Asthma Registries Market, By Country, 2015-2022 (USD Million)
Table 25 Europe: Asthma Registries Market, By Country, 2015-2022 (USD Million)
Table 26 Asia-Pacific: Asthma Registries Market, By Country, 2015-2022 (USD Million)
Table 27 Global Chronic Kidney Disease Registries Market, By Region, 2015-2022 (USD Million)
Table 28 North America: Chronic Kidney Disease Registries Market, By Country, 2015-2022 (USD Million)
Table 29 Europe: Chronic Kidney Disease Registries Market, By Country, 2015-2022 (USD Million)
Table 30 Asia-Pacific: Chronic Kidney Disease Registries Market, By Country, 2015-2022 (USD Million)
Table 31 Global Orthopedic Registries Market, By Region, 2015-2022 (USD Million)
Table 32 North America: Orthopedic Registries Market, By Country, 2015-2022 (USD Million)
Table 33 Europe: Orthopedic Registries Market, By Country, 2015-2022 (USD Million)
Table 34 Asia-Pacific: Orthopedic Registries Market, By Country, 2015-2022 (USD Million)
Table 35 Global Other Disease Registries Market, By Region, 2015-2022 (USD Million)
Table 36 North America: Other Disease Registries Market, By Country, 2015-2022 (USD Million)
Table 37 Europe: Other Disease Registries Market, By Country, 2015-2022 (USD Million)
Table 38 Asia-Pacific: Other Disease Registries Market, By Country, 2015-2022 (USD Million)
Table 39 Global Health Service Registries Market, By Region, 2015-2022 (USD Million)
Table 40 North America: Health Service Registries Market, By Country, 2015-2022 (USD Million)
Table 41 Europe: Health Service Registries Market, By Country, 2015-2022 (USD Million)
Table 42 Asia-Pacific: Health Service Registries Market, By Country, 2015-2022 (USD Million)
Table 43 Global Product Registries Market, By Type, 2015-2022 (USD Million)
Table 44 Global Product Registries Market, By Region, 2015-2022 (USD Million)
Table 45 North America: Product Registries Market, By Country, 2015-2022 (USD Million)
Table 46 Europe: Product Registries Market, By Country, 2015-2022 (USD Million)
Table 47 Asia-Pacific: Product Registries Market, By Country, 2015-2022 (USD Million)
Table 48 Medical Device Registries Market, By Region, 2015-2022 (USD Million)
Table 49 North America: Medical Device Registries Market, By Country, 2015-2022 (USD Million)
Table 50 Europe: Medical Device Registries Market, By Country, 2015-2022 (USD Million)
Table 51 Asia-Pacific: Medical Device Registries Market, By Country, 2015-2022 (USD Million)
Table 52 Global Drug Registries Market, By Region, 2015-2022 (USD Million)
Table 53 North America: Drug Registries Market, By Country, 2015-2022 (USD Million)
Table 54 Europe: Drug Registries Market, By Country, 2015-2022 (USD Million)
Table 55 Asia-Pacific: Drug Registries Market, By Country, 2015-2022 (USD Million)
Table 56 Global Patient Registry Software Market, By Type of Software, 2015–2022 (USD Million)
Table 57 Global Standalone Patient Registry Software Market, By Region, 2015–2022 (USD Million)
Table 58 North America: Standalone Patient Registry Software Market, By Country, 2015–2022 (USD Million)
Table 59 Europe: Standalone Patient Registry Software Market, By Country, 2015–2022 (USD Million)
Table 60 Asia-Pacific: Standalone Patient Registry Software Market, By Country, 2015–2022 (USD Million)
Table 61 Global Integrated Patient Registry Software Market, By Region, 2015–2022 (USD Million)
Table 62 North America: Integrated Patient Registry Software Market, By Country, 2015–2022 (USD Million)
Table 63 Europe: Integrated Patient Registry Software Market, By Country, 2015–2022 (USD Million)
Table 64 Asia-Pacific: Integrated Patient Registry Software Market, By Country, 2015–2022 (USD Million)
Table 65 Global Patient Registry Software Market, By Pricing Model, 2015–2022 (USD Million)
Table 66 Global Subscription-Based Patient Registry Software Market , By Region, 2015–2022 (USD Million)
Table 67 North America: Subscription-Based Patient Registry Software Market, By Country, 2015–2022 (USD Million)
Table 68 Europe: Subscription-Based Patient Registry Software Market, By Country, 2015–2022 (USD Million)
Table 69 Asia-Pacific: Subscription-Based Patient Registry Software Market, By Country, 2015–2022 (USD Million)
Table 70 Global Ownership-Based Patient Registry Software Market , By Region, 2015–2022 (USD Million)
Table 71 North America: Ownership-Based Patient Registry Software Market, By Country, 2015–2022 (USD Million)
Table 72 Europe: Ownership-Based Patient Registry Software Market, By Country, 2015–2022 (USD Million)
Table 73 Asia-Pacific: Ownership-Based Patient Registry Software Market, By Country, 2015–2022 (USD Million)
Table 74 Global Patient Registry Software Market, By Deployment Model, 2015–2022 (USD Million)
Table 75 Global Patient Registry Software Market for On-Premise Models, By Region, 2015–2022 (USD Million)
Table 76 North America: Patient Registry Software Market for On-Premise Models, By Country, 2015–2022 (USD Million)
Table 77 Europe: Patient Registry Software Market for On-Premise Models, By Country, 2015–2022 (USD Million)
Table 78 Asia-Pacific: Patient Registry Software Market for On-Premise Models, By Country, 2015–2022 (USD Million)
Table 79 Global Patient Registry Software Market for Cloud-Based Models, By Region, 2015–2022 (USD Million)
Table 80 North America: Patient Registry Software Market for Cloud-Based Models, By Country, 2015–2022 (USD Million)
Table 81 Europe: Patient Registry Software Market for Cloud-Based Models, By Country, 2015–2022 (USD Million)
Table 82 Asia-Pacific: Patient Registry Software Market for Cloud-Based Models, By Country, 2015–2022 (USD Million)
Table 83 Global Patient Registry Software Market, By Type of Database, 2015–2022 (USD Million)
Table 84 Global Patient Registry Software Market for Commercial Databases, By Region, 2015–2022 (USD Million)
Table 85 North America: Patient Registry Software Market for Commercial Databases, By Country, 2015–2022 (USD Million)
Table 86 Europe: Patient Registry Software Market for Commercial Databases, By Country, 2015–2022 (USD Million)
Table 87 Asia-Pacific: Patient Registry Software Market for Commercial Databases, By Country, 2015–2022 (USD Million)
Table 88 Global Patient Registry Software Market for Public Databases, By Region, 2015–2022 (USD Million)
Table 89 North America: Patient Registry Software Market for Public Databases, By Country, 2015–2022 (USD Million)
Table 90 Europe: Patient Registry Software Market for Public Databases, By Country, 2015–2022 (USD Million)
Table 91 Asia-Pacific: Patient Registry Software Market for Public Databases, By Country, 2015–2022 (USD Million)
Table 92 Global Patient Registry Software Market, By Functionality, 2015–2022 (USD Million)
Table 93 Global Patient Registry Software Market for Population Health Management, By Region, 2015–2022 (USD Million)
Table 94 North America: Patient Registry Software Market for Population Health Management, By Country, 2015–2022 (USD Million)
Table 95 Europe: Patient Registry Software Market for Population Health Management, By Country, 2015–2022 (USD Million)
Table 96 Asia-Pacific: Patient Registry Software Market for Population Health Management, By Country, 2015–2022 (USD Million)
Table 97 Global Patient Registry Software Market for Patient Care Management, By Region, 2015–2022 (USD Million)
Table 98 North America: Patient Registry Software Market for Patient Care Management, By Country, 2015–2022 (USD Million)
Table 99 Europe: Patient Registry Software Market for Patient Care Management, By Country, 2015–2022 (USD Million)
Table 100 Asia-Pacific: Patient Registry Software Market for Patient Care Management, By Country, 2015–2022 (USD Million)
Table 101 Global Patient Registry Software Market for Health Information Exchange, By Region, 2015–2022 (USD Million)
Table 102 North America: Patient Registry Software Market for Health Information Exchange, By Country, 2015–2022 (USD Million)
Table 103 Europe: Patient Registry Software Market for Health Information Exchange, By Country, 2015–2022 (USD Million)
Table 104 Asia-Pacific: Patient Registry Software Market for Health Information Exchange, By Country, 2015–2022 (USD Million)
Table 105 Global Patient Registry Software Market for Point-Of-Care, By Region, 2015–2022 (USD Million)
Table 106 North America: Patient Registry Software Market for Point-Of-Care, By Country, 2015–2022 (USD Million)
Table 107 Europe: Patient Registry Software Market for Point-Of-Care, By Country, 2015–2022 (USD Million)
Table 108 Asia-Pacific: Patient Registry Software Market for Point-Of-Care, By Country, 2015–2022 (USD Million)
Table 109 Global Patient Registry Software Market for Product Outcome Evaluation, By Region, 2015–2022 (USD Million)
Table 110 North America: Patient Registry Software Market for Product Outcome Evaluation, By Country, 2015–2022 (USD Million)
Table 111 Europe: Patient Registry Software Market Size for Product Outcome Evaluation, By Country, 2015–2022 (USD Million)
Table 112 Asia-Pacific: Patient Registry Software Market for Product Outcome Evaluation, By Country, 2015–2022 (USD Million)
Table 113 Global Patient Registry Software Market for Medical Research & Clinical Studies, By Region, 2015–2022 (USD Million)
Table 114 North America: Patient Registry Software Market for Medical Research & Clinical Studies, By Country, 2015–2022 (USD Million)
Table 115 Europe: Patient Registry Software Market for Medical Research & Clinical Studies, By Country, 2015–2022 (USD Million)
Table 116 Asia-Pacific: Patient Registry Software Market for Medical Research & Clinical Studies, By Country, 2015–2022 (USD Million)
Table 117 Global Patient Registry Software Market, By End User, 2015-2022 (USD Million)
Table 118 Global Patient Registry Software Market for Government Organizations & Third-Party Administrators, By Region, 2015-2022 (USD Million)
Table 119 North America: Patient Registry Software Market for Government Organizations & Third-Party Administrators, By Country, 2015-2022 (USD Million)
Table 120 Europe: Patient Registry Software Market for Government Organizations & Third-Party Administrators, By Country, 2015-2022 (USD Million)
Table 121 Asia-Pacific: Patient Registry Software Market for Government Organizations & Third-Party Administrators, By Country, 2015-2022 (USD Million)
Table 122 Global Patient Registry Software Market for Hospitals and Medical Practices, By Region, 2015-2022 (USD Million)
Table 123 North America: Patient Registry Software Market for Hospitals and Medical Practices, By Country, 2015-2022 (USD Million)
Table 124 Europe: Patient Registry Software Market for Hospitals and Medical Practices, By Country, 2015-2022 (USD Million)
Table 125 Asia-Pacific: Patient Registry Software Market for Hospitals and Medical Practices, By Country, 2015-2022 (USD Million)
Table 126 Global Patient Registry Software Market for Private Payers, By Region, 2015-2022 (USD Million)
Table 127 North America: Patient Registry Software Market for Private Payers, By Country, 2015-2022 (USD Million)
Table 128 Europe: Patient Registry Software Market for Private Payers, By Country, 2015-2022 (USD Million)
Table 129 Asia-Pacific: Patient Registry Software Market for Private Payers, By Country, 2015-2022 (USD Million)
Table 130 Global Patient Registry Software Market for Pharmaceutical and Medical Device Companies, By Region, 2015-2022 (USD Million)
Table 131 North America: Patient Registry Software Market for Pharmaceutical and Medical Device Companies, By Country, 2015-2022 (USD Million)
Table 132 Europe: Patient Registry Software Market for Pharmaceutical and Medical Device Companies, By Country, 2015-2022 (USD Million)
Table 133 Asia-Pacific: Patient Registry Software Market for Pharmaceutical and Medical Device Companies, By Country, 2015-2022 (USD Million)
Table 134 Global Patient Registry Software Market for Research Centers, By Region, 2015-2022 (USD Million)
Table 135 North America: Patient Registry Software Market for Research Centers, By Country, 2015-2022 (USD Million)
Table 136 Europe: Patient Registry Software Market for Research Centers, By Country, 2015-2022 (USD Million)
Table 137 Asia-Pacific: Patient Registry Software Market for Research Centers, By Country, 2015-2022 (USD Million)
Table 138 Patient Registry Software Market, By Region, 2015–2022 (USD Million)
Table 139 North America: Patient Registry Software Market, By Country, 2015–2022 (USD Million)
Table 140 North America: Patient Registry Software Market, By Type of Software, 2015–2022 (USD Million)
Table 141 North America: Patient Registry Software Market, By Pricing Model, 2015–2022 (USD Million)
Table 142 North America: Patient Registry Software Market, By Deployment Model, 2015–2022 (USD Million)
Table 143 North America: Patient Registry Software Market, By Type of Registry, 2015–2022 (USD Million)
Table 144 North America: Product Registries Market, By Type, 2015–2022 (USD Million)
Table 145 North America: Disease Registries Market, By Type, 2015–2022 (USD Million)
Table 146 North America: Patient Registry Software Market, By Functionality, 2015–2022 (USD Million)
Table 147 North America: Patient Registry Software Market, By End User, 2015–2022 (USD Million)
Table 148 North America: Patient Registry Software Market, By Type of Database, 2015–2022 (USD Million)
Table 149 US: Patient Registry Software Market, By Type of Software, 2015–2022 (USD Million)
Table 150 US: Patient Registry Software Market, By Pricing Model, 2015–2022 (USD Million)
Table 151 US: Patient Registry Software Market, By Deployment Model, 2015–2022 (USD Million)
Table 152 US: Patient Registry Software Market, By Type of Registry, 2015–2022 (USD Million)
Table 153 US: Product Registries Market, By Type, 2015–2022 (USD Million)
Table 154 US: Disease Registries Market, By Type, 2015–2022 (USD Million)
Table 155 US: Patient Registry Software Market, By Functionality, 2015–2022 (USD Million)
Table 156 US: Patient Registry Software Market, By End User, 2015–2022 (USD Million)
Table 157 US: Patient Registry Software Market, By Type of Database, 2015–2022 (USD Million)
Table 158 Canada: Patient Registry Software Market, By Type of Software, 2015–2022 (USD Million)
Table 159 Canada: Patient Registry Software Market, By Pricing Model, 2015–2022 (USD Million)
Table 160 Canada: Patient Registry Software Market, By Deployment Model, 2015–2022 (USD Million)
Table 161 Canada: Patient Registry Software Market, By Type of Registry, 2015–2022 (USD Million)
Table 162 Canada: Product Registries Market, By Type, 2015–2022 (USD Million)
Table 163 Canada: Disease Registries Market, By Type, 2015–2022 (USD Million)
Table 164 Canada: Patient Registry Software Market, By Functionality, 2015–2022 (USD Million)
Table 165 Canada: Patient Registry Software Market, By End User, 2015–2022 (USD Million)
Table 166 Canada: Patient Registry Software Market, By Type of Database, 2015–2022 (USD Million)
Table 167 Europe: Patient Registry Software Market, By Country, 2015–2022 (USD Million)
Table 168 Europe: Patient Registry Software Market, By Type of Software, 2015–2022 (USD Million)
Table 169 Europe: Patient Registry Software Market, By Pricing Model, 2015–2022 (USD Million)
Table 170 Europe: Patient Registry Software Market, By Deployment Model, 2015–2022 (USD Million)
Table 171 Europe: Patient Registry Software Market, By Type of Registry, 2015–2022 (USD Million)
Table 172 Europe: Product Registries Market, By Type, 2015–2022 (USD Million)
Table 173 Europe: Disease Registries Market, By Type, 2015–2022 (USD Million)
Table 174 Europe: Patient Registry Software Market, By Functionality, 2015–2022 (USD Million)
Table 175 Europe: Patient Registry Software Market, By End User, 2015–2022 (USD Million)
Table 176 Europe: Patient Registry Software Market, By Type of Database, 2015–2022 (USD Million)
Table 177 Germany: Patient Registry Software Market, By Type of Software, 2015–2022 (USD Million)
Table 178 Germany: Patient Registry Software Market, By Pricing Model, 2015–2022 (USD Million)
Table 179 Germany: Patient Registry Software Market, By Deployment Model, 2015–2022 (USD Million)
Table 180 Germany: Patient Registry Software Market, By Type of Registry, 2015–2022 (USD Million)
Table 181 Germany: Product Registries Market, By Type, 2015–2022 (USD Million)
Table 182 Germany: Disease Registries Market, By Type, 2015–2022 (USD Million)
Table 183 Germany: Patient Registry Software Market, By Functionality, 2015–2022 (USD Million)
Table 184 Germany: Patient Registry Software Market, By End User, 2015–2022 (USD Million)
Table 185 Germany: Patient Registry Software Market, By Type of Database, 2015–2022 (USD Million)
Table 186 France: Patient Registry Software Market, By Type of Software, 2015–2022 (USD Million)
Table 187 France: Patient Registry Software Market, By Pricing Model, 2015–2022 (USD Million)
Table 188 France: Patient Registry Software Market, By Deployment Model, 2015–2022 (USD Million)
Table 189 France: Patient Registry Software Market, By Type of Registry, 2015–2022 (USD Million)
Table 190 France: Product Registries Market, By Type, 2015–2022 (USD Million)
Table 191 France: Disease Registries Market, By Type, 2015–2022 (USD Million)
Table 192 France: Patient Registry Software Market, By Functionality, 2015–2022 (USD Million)
Table 193 France: Patient Registry Software Market, By End User, 2015–2022 (USD Million)
Table 194 France: Patient Registry Software Market, By Type of Database, 2015–2022 (USD Million)
Table 195 UK: Patient Registry Software Market, By Type of Software, 2015–2022 (USD Million)
Table 196 UK: Patient Registry Software Market, By Pricing Model, 2015–2022 (USD Million)
Table 197 UK: Patient Registry Software Market, By Deployment Model, 2015–2022 (USD Million)
Table 198 UK: Patient Registry Software Market, By Type of Registry, 2015–2022 (USD Million)
Table 199 UK: Product Registries Market, By Type, 2015–2022 (USD Million)
Table 200 UK: Disease Registries Market, By Type, 2015–2022 (USD Million)
Table 201 UK: Patient Registry Software Market, By Functionality, 2015–2022 (USD Million)
Table 202 UK: Patient Registry Software Market, By End User, 2015–2022 (USD Million)
Table 203 UK: Patient Registry Software Market, By Type of Database, 2015–2022 (USD Million)
Table 204 RoE: Patient Registry Software Market, By Type of Software, 2015–2022 (USD Million)
Table 205 RoE: Patient Registry Software Market, By Pricing Model, 2015–2022 (USD Million)
Table 206 RoE: Patient Registry Software Market, By Deployment Model, 2015–2022 (USD Million)
Table 207 RoE: Patient Registry Software Market, By Type of Registry, 2015–2022 (USD Million)
Table 208 RoE: Product Registries Market, By Type, 2015–2022 (USD Million)
Table 209 RoE: Disease Registries Market, By Type, 2015–2022 (USD Million)
Table 210 RoE: Patient Registry Software Market, By Functionality, 2015–2022 (USD Million)
Table 211 RoE: Patient Registry Software Market, By End User, 2015–2022 (USD Million)
Table 212 RoE: Patient Registry Software Market, By Type of Database, 2015–2022 (USD Million)
Table 213 Asia-Pacific: Patient Registry Software Market, By Country, 2015–2022 (USD Million)
Table 214 Asia-Pacific: Patient Registry Software Market, By Type of Software, 2015–2022 (USD Million)
Table 215 Asia-Pacific: Patient Registry Software Market, By Pricing Model, 2015–2022 (USD Million)
Table 216 Asia-Pacific: Patient Registry Software Market, By Deployment Model, 2015–2022 (USD Million)
Table 217 Asia-Pacific: Patient Registry Software Market, By Type of Registry, 2015–2022 (USD Million)
Table 218 Asia-Pacific: Product Registries Market, By Type, 2015–2022 (USD Million)
Table 219 Asia-Pacific: Disease Registries Market, By Type, 2015–2022 (USD Million)
Table 220 Asia-Pacific: Patient Registry Software Market, By Functionality, 2015–2022 (USD Million)
Table 221 Asia-Pacific: Patient Registry Software Market, By End User, 2015–2022 (USD Million)
Table 222 Asia-Pacific: Patient Registry Software Market, By Type of Database, 2015–2022 (USD Million)
Table 223 Japan: Patient Registry Software Market, By Type of Software, 2015–2022 (USD Million)
Table 224 Japan: Patient Registry Software Market, By Pricing Model, 2015–2022 (USD Million)
Table 225 Japan: Patient Registry Software Market, By Deployment Model, 2015–2022 (USD Million)
Table 226 Japan: Patient Registry Software Market, By Type of Registry, 2015–2022 (USD Million)
Table 227 Japan: Product Registries Market, By Type, 2015–2022 (USD Million)
Table 228 Japan: Disease Registries Market, By Type, 2015–2022 (USD Million)
Table 229 Japan: Patient Registry Software Market, By Functionality, 2015–2022 (USD Million)
Table 230 Japan: Patient Registry Software Market, By End User, 2015–2022 (USD Million)
Table 231 Japan: Patient Registry Software Market, By Type of Database, 2015–2022 (USD Million)
Table 232 China: Patient Registry Software Market, By Type of Software, 2015–2022 (USD Million)
Table 233 China: Patient Registry Software Market, By Pricing Model, 2015–2022 (USD Million)
Table 234 China: Patient Registry Software Market, By Deployment Model, 2015–2022 (USD Million)
Table 235 China: Patient Registry Software Market, By Type of Registry, 2015–2022 (USD Million)
Table 236 China: Product Registries Market, By Type, 2015–2022 (USD Million)
Table 237 China: Disease Registries Market, By Type, 2015–2022 (USD Million)
Table 238 China: Patient Registry Software Market, By Functionality, 2015–2022 (USD Million)
Table 239 China: Patient Registry Software Market, By End User, 2015–2022 (USD Million)
Table 240 China: Patient Registry Software Market, By Type of Database, 2015–2022 (USD Million)
Table 241 India: Patient Registry Software Market, By Type of Software, 2015–2022 (USD Million)
Table 242 India: Patient Registry Software Market, By Pricing Model, 2015–2022 (USD Million)
Table 243 India: Patient Registry Software Market, By Deployment Model, 2015–2022 (USD Million)
Table 244 India: Patient Registry Software Market, By Type of Registry, 2015–2022 (USD Million)
Table 245 India: Product Registries Market, By Type, 2015–2022 (USD Million)
Table 246 India: Disease Registries Market, By Type, 2015–2022 (USD Million)
Table 247 India: Patient Registry Software Market, By Functionality, 2015–2022 (USD Million)
Table 248 India: Patient Registry Software Market, By End User, 2015–2022 (USD Million)
Table 249 India: Patient Registry Software Market, By Type of Database, 2015–2022 (USD Million)
Table 250 RoAPAC: Patient Registry Software Market, By Type of Software, 2015–2022 (USD Million)
Table 251 RoAPAC: Patient Registry Software Market, By Pricing Model, 2015–2022 (USD Million)
Table 252 RoAPAC: Patient Registry Software Market, By Deployment Model, 2015–2022 (USD Million)
Table 253 RoAPAC: Patient Registry Software Market, By Type of Registry, 2015–2022 (USD Million)
Table 254 RoAPAC: Product Registries Market, By Type, 2015–2022 (USD Million)
Table 255 RoAPAC: Disease Registries Market, By Type, 2015–2022 (USD Million)
Table 256 RoAPAC: Patient Registry Software Market, By Functionality, 2015–2022 (USD Million)
Table 257 RoAPAC: Patient Registry Software Market, By End User, 2015–2022 (USD Million)
Table 258 RoAPAC: Patient Registry Software Market, By Type of Database, 2015–2022 (USD Million)
Table 259 RoW: Patient Registry Software Market, By Type of Software, 2015–2022 (USD Million)
Table 260 RoW: Patient Registry Software Market, By Pricing Model, 2015–2022 (USD Million)
Table 261 RoW: Patient Registry Software Market, By Deployment Model, 2015–2022 (USD Million)
Table 262 RoW: Patient Registry Software Market, By Type of Registry, 2015–2022 (USD Million)
Table 263 RoW: Product Registries Market, By Type, 2015–2022 (USD Million)
Table 264 RoW: Disease Registries Market, By Type, 2015–2022 (USD Million)
Table 265 RoW: Patient Registry Software Market, By Functionality, 2015–2022 (USD Million)
Table 266 RoW: Patient Registry Software Market, By End User, 2015–2022 (USD Million)
Table 267 RoW: Patient Registry Software Market, By Type of Database, 2015–2022 (USD Million)
Table 268 Ranking of Top Players in the Patient Registry Software Market
 
 
List of Figures (51 Figures)
 
Figure 1 Research Design
Figure 2 Market Size Estimation: Bottom-Up Approach
Figure 3 Market Size Estimation: Top-Down Approach
Figure 4 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 5 Data Triangulation Methodology
Figure 6 Key Data From Secondary Sources
Figure 7 Key Data From Primary Sources
Figure 8 Disease Registries to Register High Growth During the Forecast Period
Figure 9 Standalone Software Segment to Dominate the Patient Registry Software Market, By Type of Software, 2017–2022
Figure 10 Subscription-Based Software Segment to Register Significant Growth During the Forecast Period
Figure 11 Cloud-Based Models to Grow at the Highest CAGR During the Forecast Period
Figure 12 Public Databases to Grow at the Highest CAGR During the Forecast Period
Figure 13 Patient Care Management Segment to Grow at the Highest CAGR During the Forecast Period
Figure 14 Government Organizations & TPAs to Dominate the Market in 2017
Figure 15 North America is Expected to Hold the Largest Share in 2017
Figure 16 Emergence of Cloud-Based Patient Registry Solutions to Offer Growth Opportunities to Market Players During the Forecast Period
Figure 17 Integrated Software to Register the Highest Growth Rate Between 2017 & 2022
Figure 18 On-Premise Models to Dominate the Patient Registry Software Market in 2017
Figure 19 Commercial Databases Will Continue to Dominate the Patient Registry Software Market in 2022
Figure 20 Hospitals & Medical Practices Segment to Witness the Highest CAGR During the Forecast Period
Figure 21 China to Witness High Growth in the Patient Registry Software Market From 2017 to 2022
Figure 22 Patient Registry Software: Drivers, Restraints, Opportunities, and Challenges
Figure 23 Disease Registries Segment to Witness Highest Growth During the Forecast Period
Figure 24 Cancer Registries to Grow at the Highest CAGR During the Forecast Period
Figure 25 North America to Dominate the Health Service Registries Market During the Forecast Period
Figure 26 Medical Device Registries to Dominate the Product Registries Market During the Forecast Period
Figure 27 Integrated Software Segment to Register the Highest Growth During the Forecast Period
Figure 28 North America to Dominate the Integrated Software Market in 2017
Figure 29 Subscription Model to Dominate the Patient Registry Software Market During the Forecast Period
Figure 30 North America to Dominate the Ownership-Based Patient Registry Software Market in 2017
Figure 31 Cloud-Based Models to Witness the Highest Growth Rate During the Forecast Period
Figure 32 North America to Dominate the Patient Registry Software Market for Cloud-Based Software Models in 2017
Figure 33 Commercial Databases to Dominate the Market During the Forecast Period
Figure 34 North America to Dominate the Public Databases Market in 2017
Figure 35 Patient Care Management Segment to Witness Highest Growth During the Forecast Period
Figure 36 North America to Dominate the Patient Care Management Market During the Forecast Period
Figure 37 Hospitals and Medical Practices Segment to Witness Highest Growth During the Forecast Period
Figure 38 Asia-Pacific Patient Registry Software Market for Hospitals and Medical Practices to Grow at the Highest CAGR During the Forecast Period
Figure 39 Asia-Pacific to Register the Highest Growth Rate During the Forecast Period
Figure 40 North America: Patient Registry Software Market Snapshot
Figure 41 Europe: Patient Registry Software Market Snapshot
Figure 42 Asia-Pacific: Patient Registry Software Market Snapshot
Figure 43 RoW: Patient Registry Software Market Snapshot
Figure 44 Competitive Leadership Mapping, 2017
Figure 45 IBM Corporation: Company Snapshot
Figure 46 Premier, Inc.: Company Snapshot
Figure 47 Ifa Systems AG : Company Snapshot
Figure 48 Inc Research Holdings, Inc.: Company Snapshot
Figure 49 McKesson Corporation: Company Snapshot
Figure 50 Quintiles IMS Holdings, Inc.: Company Snapshot
Figure 51 Optum, Inc: Company Snapshot

The global patient registry software market is expected to reach USD 1,429.1 Million by 2022 from USD 807.4 Million in 2017, at a CAGR of 12.1%. A number of factors such as government initiatives to build patient registries, rising pressure to improve the quality of care & reduce healthcare costs, rising adoption of EHRs, and growing use of patient registry data for post-marketing surveillance are driving the growth of this market. With the rapidly growing geriatric population and increasing prevalence of chronic diseases, the necessity of population health management has increased. This draws attention towards registry tools. The high adoption of information technology across the globe also supports the growth of this market.

This report segments this market based on type of registry, pricing model, deployment model, type of database, functionality, end user, type of software, and region. In the basis of functionality, the patient registry software market is segmented into population health management (PHM), patient care management, health information exchange (HIE), point-of-care, product outcome evaluation, and medical research & clinical studies. The population health management segment is estimated to dominate the market in 2017. This can primarily be attributed to increasing government initiatives for encouraging PHM.

The global patient registry software market, by end user is segmented into government organizations & TPAs (third-party administrators); hospitals and medical practices; private payers; pharmaceutical, biotechnology, and medical device companies; and research centers. In 2017, the hospitals and medical practices segment is expected to witness the highest growth during the forecast period. The high growth rate of this segment can be attributed to factors like increasing focus on improving the quality of patient care and growing adoption of EHRs.

On the basis of deployment model, the patient registry software market is further divided into on-premise and cloud-based models. The cloud-based models segment is expected to grow at the highest CAGR during the forecast period. The main factors aiding its growth are cost-effectiveness, large storage capacity, easy accessibility, flexibility, and regular automatic upgradation.

Patient Registry Software Market

Geographically, the patient registry software market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). In 2017, North America is expected to dominate the market, followed by Europe. The large share of the North American market is attributed to the factors such as presence of major patient registry software developing players and the high adoption rate of these solutions in the region. Other drivers include the increasing need to integrate healthcare systems, government funding for developing patient registries, rising focus on population health management & health information exchange, increasing adoption of HCIT as a cost-containment measure, and increasing participation of non-profit and private organizations in improving patient care quality.

Some prominent players in the patient registry software market are Phytel, Inc. (US), QUINTILES IMS HOLDINGS, INC. (US), Liaison Technologies. (US), ImageTrend, Inc. (US), FIGmd, Inc. (US), McKesson Corporation (US), CECity.com Inc. (a Premier, Inc. Company) (US), Dacima Software Inc. (US), Global Vision Technologies, Inc. (US), ifa systems AG, (Germany), INC RESEARCH HOLDINGS, INC. (US), M2S (A Medstreaming Company) (US), Optum, Inc (A part of UnitedHealth Group Incorporated) (US), EVADO Pty. Ltd. (Australia), and Velos, Inc. (US). These companies are focusing on strategies such as product launches, expansions, agreements, collaborations, and acquisitions to increase their offerings in the market and cater to the increasing demand for patient registry software.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit https://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth Healthcare IT Markets on KnowledgeStore
Request Demo